Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor

被引：0
|
作者：
Steven C Katz
Rachel A Burga
Seema Naheed
Lauren A Licata
Mitchell Thorn
Doreen Osgood
Cang T Nguyen
N Joseph Espat
Jonathan A Fletcher
Richard P Junghans
机构：
[1] RI/Boston University School of Medicine,Roger Williams Medical Center, Department of Surgery, Providence
[2] RI/Boston University School of Medicine,Roger Williams Medical Center, Department of Medicine, Providence
[3] Brigham and Women's Hospital and Harvard Medical School,undefined
来源：
Journal of Translational Medicine | / 11卷
关键词：
GIST; Adoptive cell therapy; Immunotherapy; and Designer T cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Advances in the Treatment of Gastrointestinal Stromal Tumor
    D'Adamo, David
    ADVANCES IN THERAPY, 2009, 26 (09) : 826 - 837
  • [32] Radiotherapy in the treatment of gastrointestinal stromal tumor
    Knowlton, Christin A.
    Brady, Luther W.
    Heintzelman, Rebecca C.
    RARE TUMORS, 2011, 3 (04) : 111 - 113
  • [33] Anti-KIT Monoclonal Antibody Treatment Enhances the Antitumor Activity of Immune Checkpoint Inhibitors by Reversing Tumor-Induced Immunosuppression
    Garton, Andrew J.
    Seibel, Scott
    Lopresti-Morrow, Lori
    Crew, Linda
    Janson, Neal
    Mandiyan, Sreekala
    Trombetta, E. Sergio
    Pankratz, Shannon
    LaVallee, Theresa M.
    Gedrich, Richard
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (04) : 671 - 680
  • [34] Inhibition of KIT RNAi mediated with adenovirus in gastrointestinal stromal tumor xenograft
    Wang, Tian-Bao
    Huang, Wen-Sheng
    Lin, Wei-Hao
    Shi, Han-Ping
    Dong, Wen-Guang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (40) : 5122 - 5129
  • [35] MicroRNA profiling in KIT and SDH mutated Gastrointestinal stromal tumor (GIST)
    Ravegnini, G.
    Pantaleo, M. A.
    Astolfi, A.
    Biasco, G.
    Hrelia, P.
    Nannini, M.
    Angelini, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 30 - 30
  • [36] Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor
    Kang, Guhyun
    Bae, Byung Noe
    Sohn, Byeong Seok
    Pyo, Jung-Soo
    Kang, Gu Hyum
    Kim, Kyoung-Mee
    TARGETED ONCOLOGY, 2015, 10 (04) : 597 - 601
  • [37] Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor
    Kim, Teresa S.
    Cavnar, Michael J.
    Cohen, Noah A.
    Sorenson, Eric C.
    Greer, Jonathan B.
    Seifert, Adrian M.
    Crawley, Megan H.
    Green, Benjamin L.
    Popow, Rachel
    Pillarsetty, Nagavarakishore
    Veach, Darren R.
    Ku, Anson T.
    Rossi, Ferdinand
    Besmer, Peter
    Antonescu, Cristina R.
    Zeng, Shan
    DeMatteo, Ronald P.
    CLINICAL CANCER RESEARCH, 2014, 20 (09) : 2350 - 2362
  • [38] Gastrointestinal stromal tumor with a novel mutation of KIT proto-oncogene
    Fukuda, R
    Hamamoto, N
    Uchida, Y
    Furuta, K
    Katsube, T
    Kazumori, H
    Ishihara, S
    Amano, K
    Adachi, K
    Watanabe, M
    Kinoshita, Y
    INTERNAL MEDICINE, 2001, 40 (04) : 301 - 303
  • [39] The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations
    Boikos, Sosipatros A.
    Stratakis, Constantine A.
    ENDOCRINE, 2014, 47 (02) : 401 - 408
  • [40] Inhibition of KIT RNAi mediated with adenovirus in gastrointestinal stromal tumor xenograft
    Tian-Bao Wang
    World Journal of Gastroenterology, 2010, 16 (40) : 5122 - 5129
12345